We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADNT icon
276
Adient
ADNT
$1.62B
$1.05M 0.13%
46,562
+29,239
+169% +$669K
DCI icon
277
Donaldson
DCI
$10.8B
$1.04M 0.12%
+14,171
New +$1.02M
CNQ icon
278
Canadian Natural Resources
CNQ
$93.4B
$1.04M 0.12%
+31,315
New +$1.09M
TRS icon
279
TriMas Corp
TRS
$1.45B
$1.04M 0.12%
40,710
+19,887
+96% +$499K
KNTK icon
280
Kinetik
KNTK
$3.59B
$1.04M 0.12%
+22,955
New +$993K
CBT icon
281
Cabot Corp
CBT
$4.61B
$1.04M 0.12%
9,263
-6,940
-43% -$692K
SWTX
282
DELISTED
SpringWorks Therapeutics
SWTX
$1.03M 0.12%
32,016
+25,124
+365% +$939K
MBIN icon
283
Merchants Bancorp
MBIN
$2.22B
$1.02M 0.12%
22,764
+14,385
+172% +$638K
TWLO icon
284
Twilio
TWLO
$29.5B
$1.02M 0.12%
+15,687
New +$939K
PWP icon
285
Perella Weinberg Partners
PWP
$1.18B
$1.02M 0.12%
52,858
+7,730
+17% +$142K
FRPT icon
286
Freshpet
FRPT
$2.92B
$1.02M 0.12%
+7,427
New +$973K
PRO
287
DELISTED
PROS Holdings
PRO
$1.01M 0.12%
54,735
+45,095
+468% +$953K
DNUT icon
288
Krispy Kreme
DNUT
$562M
$1.01M 0.12%
+94,117
New +$1.02M
EIG icon
289
Employers Holdings
EIG
$906M
$1.01M 0.12%
21,039
+4,328
+26% +$200K
TNC icon
290
Tennant Co
TNC
$1.48B
$1.01M 0.12%
10,493
+5,039
+92% +$492K
POWL icon
291
Powell Industries
POWL
$7.99B
$998K 0.12%
+13,488
New +$734K
HAIN icon
292
Hain Celestial
HAIN
$46M
$996K 0.12%
115,456
+19,793
+21% +$148K
ADUS icon
293
Addus HomeCare
ADUS
$2.16B
$993K 0.12%
7,468
+5,713
+326% +$721K
VCTR icon
294
Victory Capital Holdings
VCTR
$6.23B
$991K 0.12%
17,896
+1,246
+7% +$64.3K
HALO icon
295
Halozyme
HALO
$9.66B
$988K 0.12%
+17,264
New +$990K
BLBD icon
296
Blue Bird Corp
BLBD
$2.41B
$979K 0.12%
20,403
-10,279
-34% -$508K
KNSA icon
297
Kiniksa Pharmaceuticals
KNSA
$4.89B
$975K 0.12%
39,004
+23,934
+159% +$583K
VRE
298
DELISTED
Veris Residential
VRE
$970K 0.12%
54,320
-9,623
-15% -$159K
TRI icon
299
Thomson Reuters
TRI
$42.7B
$968K 0.12%
5,585
+482
+9% +$81.4K
BDX icon
300
Becton Dickinson
BDX
$43.8B
$963K 0.12%
3,995
-8,123
-67% -$1.9M
10 11
12
13 14

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.